Fundraising FoxParagon Bioservices
Baltimore, US · Founded 2015 · Delaware corporation · 3 known investors
Find your way into Paragon Bioservices
Each arrow is one introduction. Sign up to fill in the first one.
Ask Paul VerHoeve to introduce you to Marco A. Chacón
You →Paul · together at Havencrest Capital Management →Marco
Sign up to find every way you can get introduced to Paragon Bioservices
- Your email: who you already know at Paragon Bioservices, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Paragon Bioservices team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Industry-leading private-equity backed CDMO focused on development and manufacturing of cutting-edge biopharmaceuticals
Founders & leadership
Paragon Bioservices was founded in 2015 by Marco Chacon.
Board
Investors · 3
How we know: Camden Partners's portfolio page · funding news · Not right? Tell us
How we know: Havencrest Capital Management's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$22.9M disclosed across 4 rounds · 2014–2018
▶$5MraisedAug 2018 · 9 investors · BiotechnologyRule 506(b)
- Robert RocheDirector
- Kapila RatnamDirector
- Patrick HervyDirector
- Peter BuzyExecutive Officer, Director
- Donald HughesDirector
- Marco ChaconDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $10.4K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.4MraisedMay 2017 · 9 investors · BiotechnologyRule 506(b)
- Marco ChaconDirector
- Robert RocheDirector
- Patrick HervyDirector
- Donald HughesDirector
- Kapila RatnamDirector
- Peter BuzyExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Minimum investment
- $20K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2MraisedAug 2015 · 7 investors · BiotechnologyRule 506(b)
- Marco ChaconExecutive Officer, Director
- Patrick HervyDirector
- Christopher KerseyDirector
- Kapila RatnamDirector
- Peter BuzyExecutive Officer
- Offering amount
- $4M
- Amount sold
- $2M
- First sale
- Aug 2015
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$13.5MraisedNov 2014 · 7 investors · BiotechnologyRule 506(b)
- Marco ChaconExecutive Officer, Director
- Patrick HervyDirector
- Kapila RatnamDirector
- Peter BuzyExecutive Officer
- Christopher KerseyDirector
- Offering amount
- $13.5M
- Amount sold
- $13.5M
- Sales commissions
- $624.4K
- Placement agents
- 1st Bridgehouse Securities, LLC
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Paragon Bioservices do?
- Industry-leading private-equity backed CDMO focused on development and manufacturing of cutting-edge biopharmaceuticals
- Who founded Paragon Bioservices?
- Paragon Bioservices was founded by Marco Chacon in 2015.
- Who are Paragon Bioservices's investors?
- Paragon Bioservices's investors include Camden Partners, Havencrest Capital Management, NewSpring Capital.
- How much funding has Paragon Bioservices raised?
- Paragon Bioservices has disclosed $22.9M raised across 4 rounds.
- Where is Paragon Bioservices headquartered?
- Paragon Bioservices is headquartered in Baltimore, US.